Global Erectile Dysfunction Drugs Market Insights and Forecast to 2027

    • ID: AR3075062
    • 11 June, 2021
    • Other
    • Region: Global
    • 116 Pages
    • QYResearch

    1 Study Coverage

    • 1.1 Erectile Dysfunction Drugs Product Introduction
    • 1.2 Market by Type
      • 1.2.1 Global Erectile Dysfunction Drugs Market Size Growth Rate by Type
      • 1.4.2 Sildenafil
      • 1.4.3 Tadalafil
      • 1.2.4 Others
    • 1.3 Market by Application
      • 1.3.1 Global Erectile Dysfunction Drugs Market Size Growth Rate by Application
      • 1.3.2 Hospital Pharmacies
      • 1.3.3 Private Clinics
      • 1.3.4 Retail Pharmacies
      • 1.3.5 E-Commerce (B2B)
      • 1.3.6 E-Commerce (B2C)
    • 1.4 Study Objectives
    • 1.5 Years Considered

    2 Executive Summary

    • 2.1 Global Erectile Dysfunction Drugs Sales Estimates and Forecasts 2016-2027
    • 2.2 Global Erectile Dysfunction Drugs Revenue Estimates and Forecasts 2016-2027
    • 2.3 Global Erectile Dysfunction Drugs Revenue by Region: 2016 VS 2021 VS 2027
    • 2.4 Global Top Erectile Dysfunction Drugs Regions by Sales
      • 2.4.1 Global Top Erectile Dysfunction Drugs Regions by Sales (2016-2021)
      • 2.4.2 Global Top Erectile Dysfunction Drugs Regions by Sales (2022-2027)
    • 2.5 Global Top Erectile Dysfunction Drugs Regions by Revenue
      • 2.5.1 Global Top Erectile Dysfunction Drugs Regions by Revenue (2016-2021)
      • 2.5.2 Global Top Erectile Dysfunction Drugs Regions by Revenue (2022-2027)
    • 2.6 North America
    • 2.7 Europe
    • 2.8 Asia-Pacific
    • 2.9 Latin America
    • 2.10 Middle East & Africa

    3 Competition by Manufacturers

    • 3.1 Global Erectile Dysfunction Drugs Sales by Manufacturers
      • 3.1.1 Global Top Erectile Dysfunction Drugs Manufacturers by Sales (2016-2021)
      • 3.1.2 Global Top Erectile Dysfunction Drugs Manufacturers Market Share by Sales (2016-2021)
      • 3.1.3 Global Top 10 and Top 5 Companies by Erectile Dysfunction Drugs Sales in 2020
    • 3.2 Global Erectile Dysfunction Drugs Revenue by Manufacturers
      • 3.2.1 Global Top Erectile Dysfunction Drugs Manufacturers by Revenue (2016-2021)
      • 3.2.2 Global Top Erectile Dysfunction Drugs Manufacturers Market Share by Revenue (2016-2021)
      • 3.2.3 Global Top 10 and Top 5 Companies by Erectile Dysfunction Drugs Revenue in 2020
    • 3.3 Global Erectile Dysfunction Drugs Sales Price by Manufacturers
    • 3.4 Analysis of Competitive Landscape
      • 3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
      • 3.4.2 Global Erectile Dysfunction Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
      • 3.4.3 Global Erectile Dysfunction Drugs Manufacturers Geographical Distribution
    • 3.5 Mergers & Acquisitions, Expansion Plans

    4 Market Size by Type

    • 4.1 Global Erectile Dysfunction Drugs Sales by Type
      • 4.1.1 Global Erectile Dysfunction Drugs Historical Sales by Type (2016-2021)
      • 4.1.2 Global Erectile Dysfunction Drugs Forecasted Sales by Type (2022-2027)
      • 4.1.3 Global Erectile Dysfunction Drugs Sales Market Share by Type (2016-2027)
    • 4.2 Global Erectile Dysfunction Drugs Revenue by Type
      • 4.2.1 Global Erectile Dysfunction Drugs Historical Revenue by Type (2016-2021)
      • 4.2.2 Global Erectile Dysfunction Drugs Forecasted Revenue by Type (2022-2027)
      • 4.2.3 Global Erectile Dysfunction Drugs Revenue Market Share by Type (2016-2027)
    • 4.3 Global Erectile Dysfunction Drugs Price by Type
      • 4.3.1 Global Erectile Dysfunction Drugs Price by Type (2016-2021)
      • 4.3.2 Global Erectile Dysfunction Drugs Price Forecast by Type (2022-2027)

    5 Market Size by Application

    • 5.1 Global Erectile Dysfunction Drugs Sales by Application
      • 5.1.1 Global Erectile Dysfunction Drugs Historical Sales by Application (2016-2021)
      • 5.1.2 Global Erectile Dysfunction Drugs Forecasted Sales by Application (2022-2027)
      • 5.1.3 Global Erectile Dysfunction Drugs Sales Market Share by Application (2016-2027)
    • 5.2 Global Erectile Dysfunction Drugs Revenue by Application
      • 5.2.1 Global Erectile Dysfunction Drugs Historical Revenue by Application (2016-2021)
      • 5.2.2 Global Erectile Dysfunction Drugs Forecasted Revenue by Application (2022-2027)
      • 5.2.3 Global Erectile Dysfunction Drugs Revenue Market Share by Application (2016-2027)
    • 5.3 Global Erectile Dysfunction Drugs Price by Application
      • 5.3.1 Global Erectile Dysfunction Drugs Price by Application (2016-2021)
      • 5.3.2 Global Erectile Dysfunction Drugs Price Forecast by Application (2022-2027)

    6 North America

    • 6.1 North America Erectile Dysfunction Drugs Market Size by Type
      • 6.1.1 North America Erectile Dysfunction Drugs Sales by Type (2016-2027)
      • 6.1.2 North America Erectile Dysfunction Drugs Revenue by Type (2016-2027)
    • 6.2 North America Erectile Dysfunction Drugs Market Size by Application
      • 6.2.1 North America Erectile Dysfunction Drugs Sales by Application (2016-2027)
      • 6.2.2 North America Erectile Dysfunction Drugs Revenue by Application (2016-2027)
    • 6.3 North America Erectile Dysfunction Drugs Market Size by Country
      • 6.3.1 North America Erectile Dysfunction Drugs Sales by Country (2016-2027)
      • 6.3.2 North America Erectile Dysfunction Drugs Revenue by Country (2016-2027)
      • 6.3.3 U.S.
      • 6.3.4 Canada

    7 Europe

    • 7.1 Europe Erectile Dysfunction Drugs Market Size by Type
      • 7.1.1 Europe Erectile Dysfunction Drugs Sales by Type (2017-2027)
      • 7.1.2 Europe Erectile Dysfunction Drugs Revenue by Type (2017-2027)
    • 7.2 Europe Erectile Dysfunction Drugs Market Size by Application
      • 7.2.1 Europe Erectile Dysfunction Drugs Sales by Application (2017-2027)
      • 7.2.2 Europe Erectile Dysfunction Drugs Revenue by Application (2017-2027)
    • 7.3 Europe Erectile Dysfunction Drugs Market Size by Country
      • 7.3.1 Europe Erectile Dysfunction Drugs Sales by Country (2017-2027)
      • 7.3.2 Europe Erectile Dysfunction Drugs Revenue by Country (2017-2027)
      • 7.3.3 Germany
      • 7.3.4 France
      • 7.3.5 U.K.
      • 7.3.6 Italy
      • 7.3.7 Russia

    8 Asia Pacific

    • 8.1 Asia Pacific Erectile Dysfunction Drugs Market Size by Type
      • 8.1.1 Asia Pacific Erectile Dysfunction Drugs Sales by Type (2018-2027)
      • 8.1.2 Asia Pacific Erectile Dysfunction Drugs Revenue by Type (2018-2027)
    • 8.2 Asia Pacific Erectile Dysfunction Drugs Market Size by Application
      • 8.2.1 Asia Pacific Erectile Dysfunction Drugs Sales by Application (2018-2027)
      • 8.2.2 Asia Pacific Erectile Dysfunction Drugs Revenue by Application (2018-2027)
    • 8.3 Asia Pacific Erectile Dysfunction Drugs Market Size by Region
      • 8.3.1 Asia Pacific Erectile Dysfunction Drugs Sales by Region (2018-2027)
      • 8.3.2 Asia Pacific Erectile Dysfunction Drugs Revenue by Region (2018-2027)
      • 8.3.3 China
      • 8.3.4 Japan
      • 8.3.5 South Korea
      • 8.3.6 India
      • 8.3.7 Australia
      • 8.3.8 Taiwan
      • 8.3.9 Indonesia
      • 8.3.10 Thailand
      • 8.3.11 Malaysia
      • 8.3.12 Philippines

    9 Latin America

    • 9.1 Latin America Erectile Dysfunction Drugs Market Size by Type
      • 9.1.1 Latin America Erectile Dysfunction Drugs Sales by Type (2019-2027)
      • 9.1.2 Latin America Erectile Dysfunction Drugs Revenue by Type (2019-2027)
    • 9.2 Latin America Erectile Dysfunction Drugs Market Size by Application
      • 9.2.1 Latin America Erectile Dysfunction Drugs Sales by Application (2019-2027)
      • 9.2.2 Latin America Erectile Dysfunction Drugs Revenue by Application (2019-2027)
    • 9.3 Latin America Erectile Dysfunction Drugs Market Size by Country
      • 9.3.1 Latin America Erectile Dysfunction Drugs Sales by Country (2019-2027)
      • 9.3.2 Latin America Erectile Dysfunction Drugs Revenue by Country (2019-2027)
      • 9.3.3 Mexico
      • 9.3.4 Brazil
      • 9.3.5 Argentina

    6 Middle East and Africa

    • 6.1 Middle East and Africa Erectile Dysfunction Drugs Market Size by Type
      • 6.1.1 Middle East and Africa Erectile Dysfunction Drugs Sales by Type (2016-2027)
      • 6.1.2 Middle East and Africa Erectile Dysfunction Drugs Revenue by Type (2016-2027)
    • 6.2 Middle East and Africa Erectile Dysfunction Drugs Market Size by Application
      • 6.2.1 Middle East and Africa Erectile Dysfunction Drugs Sales by Application (2016-2027)
      • 6.2.2 Middle East and Africa Erectile Dysfunction Drugs Revenue by Application (2016-2027)
    • 6.3 Middle East and Africa Erectile Dysfunction Drugs Market Size by Country
      • 6.3.1 Middle East and Africa Erectile Dysfunction Drugs Sales by Country (2016-2027)
      • 6.3.2 Middle East and Africa Erectile Dysfunction Drugs Revenue by Country (2016-2027)
      • 6.3.3 Turkey
      • 6.3.4 Saudi Arabia
      • 6.3.5 U.A.E

    11 Company Profiles

    • 11.1 Eli Lilly
      • 11.1.1 Eli Lilly Corporation Information
      • 11.1.2 Eli Lilly Overview
      • 11.1.3 Eli Lilly Erectile Dysfunction Drugs Sales, Price, Revenue and Gross Margin (2016-2021)
      • 11.1.4 Eli Lilly Erectile Dysfunction Drugs Product Description
      • 11.1.5 Eli Lilly Related Developments
    • 11.2 Pfizer
      • 11.2.1 Pfizer Corporation Information
      • 11.2.2 Pfizer Overview
      • 11.2.3 Pfizer Erectile Dysfunction Drugs Sales, Price, Revenue and Gross Margin (2016-2021)
      • 11.2.4 Pfizer Erectile Dysfunction Drugs Product Description
      • 11.2.5 Pfizer Related Developments
    • 11.3 Bayer
      • 11.3.1 Bayer Corporation Information
      • 11.3.2 Bayer Overview
      • 11.3.3 Bayer Erectile Dysfunction Drugs Sales, Price, Revenue and Gross Margin (2016-2021)
      • 11.3.4 Bayer Erectile Dysfunction Drugs Product Description
      • 11.3.5 Bayer Related Developments
    • 11.4 BaiYunShan General Factory
      • 11.4.1 BaiYunShan General Factory Corporation Information
      • 11.4.2 BaiYunShan General Factory Overview
      • 11.4.3 BaiYunShan General Factory Erectile Dysfunction Drugs Sales, Price, Revenue and Gross Margin (2016-2021)
      • 11.4.4 BaiYunShan General Factory Erectile Dysfunction Drugs Product Description
      • 11.4.5 BaiYunShan General Factory Related Developments
    • 11.5 S.K. Chemicals
      • 11.5.1 S.K. Chemicals Corporation Information
      • 11.5.2 S.K. Chemicals Overview
      • 11.5.3 S.K. Chemicals Erectile Dysfunction Drugs Sales, Price, Revenue and Gross Margin (2016-2021)
      • 11.5.4 S.K. Chemicals Erectile Dysfunction Drugs Product Description
      • 11.5.5 S.K. Chemicals Related Developments
    • 11.6 Teva Pharma
      • 11.6.1 Teva Pharma Corporation Information
      • 11.6.2 Teva Pharma Overview
      • 11.6.3 Teva Pharma Erectile Dysfunction Drugs Sales, Price, Revenue and Gross Margin (2016-2021)
      • 11.6.4 Teva Pharma Erectile Dysfunction Drugs Product Description
      • 11.6.5 Teva Pharma Related Developments
    • 11.7 Dong-A ST
      • 11.7.1 Dong-A ST Corporation Information
      • 11.7.2 Dong-A ST Overview
      • 11.7.3 Dong-A ST Erectile Dysfunction Drugs Sales, Price, Revenue and Gross Margin (2016-2021)
      • 11.7.4 Dong-A ST Erectile Dysfunction Drugs Product Description
      • 11.7.5 Dong-A ST Related Developments
    • 11.8 Metuchen Pharma
      • 11.8.1 Metuchen Pharma Corporation Information
      • 11.8.2 Metuchen Pharma Overview
      • 11.8.3 Metuchen Pharma Erectile Dysfunction Drugs Sales, Price, Revenue and Gross Margin (2016-2021)
      • 11.8.4 Metuchen Pharma Erectile Dysfunction Drugs Product Description
      • 11.8.5 Metuchen Pharma Related Developments
    • 11.9 Seoul Pharma
      • 11.9.1 Seoul Pharma Corporation Information
      • 11.9.2 Seoul Pharma Overview
      • 11.9.3 Seoul Pharma Erectile Dysfunction Drugs Sales, Price, Revenue and Gross Margin (2016-2021)
      • 11.9.4 Seoul Pharma Erectile Dysfunction Drugs Product Description
      • 11.9.5 Seoul Pharma Related Developments
    • 11.10 CSBIO.
      • 11.10.1 CSBIO. Corporation Information
      • 11.10.2 CSBIO. Overview
      • 11.10.3 CSBIO. Erectile Dysfunction Drugs Sales, Price, Revenue and Gross Margin (2016-2021)
      • 11.10.4 CSBIO. Erectile Dysfunction Drugs Product Description
      • 11.10.5 CSBIO. Related Developments
    • 11.1 Eli Lilly
      • 11.1.1 Eli Lilly Corporation Information
      • 11.1.2 Eli Lilly Overview
      • 11.1.3 Eli Lilly Erectile Dysfunction Drugs Sales, Price, Revenue and Gross Margin (2016-2021)
      • 11.1.4 Eli Lilly Erectile Dysfunction Drugs Product Description
      • 11.1.5 Eli Lilly Related Developments

    12 Value Chain and Sales Channels Analysis

    • 12.1 Erectile Dysfunction Drugs Value Chain Analysis
    • 12.2 Erectile Dysfunction Drugs Key Raw Materials
      • 12.2.1 Key Raw Materials
      • 12.2.2 Raw Materials Key Suppliers
    • 12.3 Erectile Dysfunction Drugs Production Mode & Process
    • 12.4 Erectile Dysfunction Drugs Sales and Marketing
      • 12.4.1 Erectile Dysfunction Drugs Sales Channels
      • 12.4.2 Erectile Dysfunction Drugs Distributors
    • 12.5 Erectile Dysfunction Drugs Customers

    13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis

    • 13.1 Erectile Dysfunction Drugs Industry Trends
    • 13.2 Erectile Dysfunction Drugs Market Drivers
    • 13.3 Erectile Dysfunction Drugs Market Challenges
    • 13.4 Erectile Dysfunction Drugs Market Restraints

    14 Key Findings in The Global Erectile Dysfunction Drugs Study

      15 Appendix

      • 15.1 Research Methodology
        • 15.1.1 Methodology/Research Approach
        • 15.1.2 Data Source
      • 15.2 Author Details

      Erectile dysfunction (ED), also known as impotence, is a type of sexual dysfunction characterized by the inability to develop or maintain an erection of the penis during sexual activity. Erectile dysfunction can have psychological consequences as it can be tied to relationship difficulties and self-image.
      The classification of Erectile Dysfunction Drugs includes Sildenafil, Tadalafil and others, and the proportion of Sildenafil in 2018 is about 99.85%, and the proportion is in decreasing trend from 2014 to 2018.Erectile Dysfunction Drugs is widely used through Hospital Pharmacies, Private Clinics, Retail Pharmacies, E-Commerce (B2B) and E-Commerce (B2C). The most proportion of Erectile Dysfunction Drugs is used for Hospital Pharmacies, and the sales proportion in 2018 is 29.24%.North America is the largest consumption place, with a consumption market share nearly 39.05% in 2018. Following North America, Europe is the second largest consumption place with the consumption market share of 30.52%. Despite of increasing demand for erectile dysfunction drugs, this market is going to experience a decline in forecast period due to patent expiration of major brands. On the contrary, it will provide the key opportunity for generic manufacturers to enter the market. Generic drugs are the promising opportunity for this market.

      Market Analysis and Insights: Global Erectile Dysfunction Drugs Market
      The global Erectile Dysfunction Drugs market is valued at US$ 5375.7 million in 2019. The market size will reach US$ 8119.6 million by the end of 2026, growing at a CAGR of 6.0% during 2021-2026.

      Global Erectile Dysfunction Drugs Scope and Market Size
      Erectile Dysfunction Drugs market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Erectile Dysfunction Drugs market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2016-2027.

      Segment by Type
      Sildenafil
      Tadalafil
      Others
      In 2018, Sildenafil accounted for a major share of 56% in the global Erectile Dysfunction Drugs market. And this product segment is poised to reach 3366.84 M USD by 2025 from 2483.77 M USD in 2019.

      Segment by Application
      Hospital Pharmacies
      Private Clinics
      Retail Pharmacies
      E-Commerce (B2B)
      E-Commerce (B2C)
      In Erectile Dysfunction Drugs market, Hospital Pharmacies segment holds an important share in terms of application, and it is expected to reach a volume of 458.57 (M Pill) by 2025, at a CAGR of 12.63% during 2018 and 2025. It means that Erectile Dysfunction Drugs will be promising in the Hospital Pharmacies field in the next couple of years.

      By Company
      Eli Lilly
      Pfizer
      Bayer
      BaiYunShan General Factory
      S.K. Chemicals
      Teva Pharma
      Dong-A ST
      Metuchen Pharma
      Seoul Pharma
      CSBIO.

      By Region
      North America
      U.S.
      Canada
      Europe
      Germany
      France
      U.K.
      Italy
      Russia
      Asia-Pacific
      China
      Japan
      South Korea
      India
      Australia
      Taiwan
      Indonesia
      Thailand
      Malaysia
      Philippines
      Vietnam
      Latin America
      Mexico
      Brazil
      Argentina
      Middle East & Africa
      Turkey
      Saudi Arabia



      Summary:
      Erectile Dysfunction Drugs Market Research Report is about Erectile Dysfunction Drugs Industry study. Get complete Erectile Dysfunction Drugs market research report published after Market Study, Industrial Analysis with Trends & Statistics. Erectile Dysfunction Drugs Market Report is a syndicated report for Investors and Manufacturer to understand Market Demand, Growth, trends and Factor Influencing market in upcoming years.



      REPORT YOU MIGHT BE INTERESTED

      $3,900.00
      $3,900.00